Definitive Contract 29FTC123C0052
- Not listed
- The U.S. Federal Trade Commission (FTC) has awarded a $74,300 firm-fixed-price definitive contract to Caerus US 1 Inc., operating as Citeline, to provide single-user access to Citeline's proprietary "Pink Sheet" and "Generics Bulletin" online services. This contract, which does not have a set-aside designation, will run through December 31, 2027. Caerus US 1 Inc. is a foreign-owned, for-profit organization that specializes in providing pharmaceutical information, drug...
- This is a $18,900.00 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Caerus US 1 Inc., a for-profit organization, for software. The contract has a completion date of October 24, 2024. The award was made on April 25, 2024, and no set-aside was used. Caerus US 1 Inc., operating as Citeline, is a provider of drug, device, company, clinical trial, and market intelligence to federal agencies,...
- The Food and Drug Administration awarded a firm fixed-price purchase order valued at approximately $596,157 to Caerus US 1 Inc. to provide access to the Pharmaprojects drug pipeline database under an existing indefinite-delivery/indefinite-quantity contract vehicle. The contract calls for a Citeline license with unlimited search capabilities of the Pharmaprojects database, which contains over 60,000 drug profiles from active development through market approval, along with development...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $233,207.00 firm-fixed-price purchase order to Caerus US 1 Inc. for a renewal license agreement to four of Informa Pharma's publications: Pharmaprojects, Pink Sheet Online, Trial Predict, and Trial Trove. This award, which does not have a set-aside designation, provides Caerus US 1 Inc.'s Citeline division with continued access to these pharmaceutical information...
- This is a $87,500.00 firm fixed-price definitive contract awarded by the Federal Trade Commission (FTC) to Health Care Cost Institute, Inc. (HCCI), a non-profit organization. The contract, which does not have a set-aside designation, is for the provision of the HCCI dataset. The contract supports the FTC's analysis of U.S. health care costs. HCCI has previously provided health care data to other federal agencies, including the Department of Commerce Bureau of Economic Analysis, as both a prime...
- This is a definitive contract awarded by the Federal Trade Commission (FTC) to Health Care Cost Institute, Inc. (HCCI), a non-profit organization, for a DATA LICENSE. The contract has a ceiling value of $70,000.00 and is a firm fixed-price contract. The contract was awarded on September 10, 2018 with a completion date of September 11, 2020. HCCI has provided similar data services and datasets to other federal agencies, including as a subcontractor to The Rand Corporation. This contract does...
- <p>The U.S. Federal Trade Commission (FTC) awarded a firm fixed-price definitive contract worth $23,000.00 to Evaluate LTD, a for-profit organization, to EVALUATE PHARMA SUBSCRIPTION. The contract has an ultimate completion date of September 26, 2025 and was awarded on September 27, 2024. The contract is not designated as a set-aside.</p>
- <p>This is a $740,000.00 Time and Materials definitive contract awarded by the Federal Trade Commission (FTC), a civilian federal agency, to Microfoundations, Inc., a for-profit subchapter S corporation. The contract is for expert consultation, analysis, and testimony services, with a period of performance ending on June 10, 2026. The contract was not set aside for any specific business type. This contract award does not appear to be associated with a larger contract vehicle.</p>
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health, a civilian agency within the Department of Health and Human Services, to Clarivate Analytics (Us) LLC for the renewal of a subscription to access a comprehensive drug database. The contract has a ceiling value of $82,022.30 and an ultimate completion date of September 7, 2019. Clarivate Analytics (Us) LLC is a global leader in providing trusted insights and analytics through subscription-based...
- This is a firm-fixed-price definitive contract awarded by the Federal Trade Commission (FTC) to Elsevier B.V., doing business as North-Holland (Publishing), for a subscription to the ScienceDirect online service. The contract has a total ceiling value of $274,052.19 and a period of performance ending on December 31, 2024. The contract was awarded on January 1, 2020 and does not have a set-aside designation. Elsevier B.V. is a global information analytics company that provides scientific,...
This is a sole source contract awarded by the Federal Trade Commission (FTC) to Caerus US 1 Inc., operating as Citeline, for a license to access Managed Markets Insight & Technology's (MMIT) Formulary Analytics data. The contract has a ceiling value of $247,500.00 and a performance period ending on September 13, 2024. The purpose is to support the FTC's Office of Policy Planning and Bureau of Economics in their research and analysis of pharmaceutical markets. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and it does not utilize any set-aside designations. Caerus US 1 Inc. is a specialized provider of pharmaceutical information, drug development data, and market intelligence to federal agencies, and it has secured numerous contracts with various components of the Department of Health and Human Services in the past.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | $0 | 4/4/25 | |
| Not listed | Not listed | $247.5k | 9/18/23 |